Passage Bio, Inc.
PASG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | $0 | -$0 | $0 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $4 | $6 | $8 | $10 |
| G&A Expenses | $4 | $5 | $6 | $0 |
| SG&A Expenses | $4 | $5 | $6 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$0 | $3 | $0 |
| Operating Expenses | $9 | $10 | $16 | $14 |
| Operating Income | -$9 | -$10 | -$16 | -$14 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $1 | $1 | $2 |
| Pre-Tax Income | -$8 | -$9 | -$15 | -$13 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8 | -$9 | -$15 | -$13 |
| % Margin | – | – | – | – |
| EPS | -2.45 | -2.96 | -4.96 | -4.1 |
| % Growth | 17.2% | 40.3% | -21% | – |
| EPS Diluted | -2.45 | -2.96 | -4.96 | -4.1 |
| Weighted Avg Shares Out | 3 | 3 | 3 | 3 |
| Weighted Avg Shares Out Dil | 3 | 3 | 3 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $1 | $1 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$7 | -$9 | -$14 | -$12 |
| % Margin | – | – | – | – |